CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Brinzolamide / brimonidine

Last Updated: November 3, 2014
Result type: Reports
Project Number: SR0403-000
Product Line: Reimbursement Review

Generic Name: Brinzolamide / brimonidine

Brand Name: Simbrinza

Manufacturer: Alcon Canada Inc.

Therapeutic Area: Glaucoma and ocular hypertension

Indications: Glaucoma and ocular hypertension

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: June 17, 2015

Recommendation Type: List